Trial Profile
A New Modified-Release Tablet Formulation of Prednisone in Patients With Rheumatoid Arthritis- Multicenter, Phase IV, Interventional Study to Assess Reduction of Morning Stiffness
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs Prednisone (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms K-IMPROvE
- Sponsors Mundipharma International
- 07 Jul 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 04 Mar 2014 New trial record